A new mouthwash from a Dublin-based company that promises to reduce the risk of bacteria infection is a big hit among healthcare professionals.
The company is Cepacolo Mouthwash, which has been in the works for several years, and it’s been marketed under a number of names, including Cepasol Mouthwash and Ceparabos, as well as the more generic Cepap, which is an acronym for CepaPap.
The new mouthwashing is supposed to help prevent bacteria from becoming resistant to common anti-bacterial agents, and is being sold as a mouthwash and a disinfectant, said founder and CEO, James Cepaco.
Cepacoolo is based in the Netherlands and was founded in 2015.
Its goal is to produce a range of mouthwash products for the healthcare community.
One of its most successful products is CEPap.
Cepapeol is an alcohol-based detergent that is also used as a shampoo, according to Cepacco’s website.
Its formulation is supposed help to remove bacteria from the skin and help prevent tooth decay.CEPap has also been used as an antiseptic and as a rinse, according a press release from Cepacia.
CePap has been a hit among medical professionals who have been recommending the product to prevent infection, according the press release.
“I would never recommend anything that has a negative impact on your health.
But when it comes to prevention, I would say Cepaca is the most effective,” Cepacio told the Irish Times.”
It is an antifungal and it has a really good antibacterial properties.”
Cepasols new formulation is expected to be available to pharmacies in the coming weeks, and CEPacol said it would be offering a 30 per cent discount on orders over €150.